线粒体的反向电子运输通过Sirt3-HIF1α-SOX2信号调节质瘤茎状
Tejinder Pal Khaket1, Suman Rimal1, Vishal Chavda1
1Department of Pathology, Stanford Cancer Institute, Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Cancer letters
|February 25, 2026
概括
线粒体反向电子运输 (RET) 推动了被称为质母细胞瘤的侵袭性脑瘤. 抑制RET阻止了质瘤干细胞的生长,并为多型质母细胞瘤 (GBM) 提供了潜在的新疗法.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 线粒体生物学 线粒体生物学
背景情况:
- 多形质母细胞瘤 (GBM) 是一种致命的脑癌,复发率高.
- 瘤干细胞 (GSCs) 驱动着GBM对治疗的抵抗力.
- 线粒体在GSC维护中的作用尚未完全理解.
研究的目的:
- 研究线粒体代谢在GSC维护中的作用.
- 确定GBM的新型治疗点.
主要方法:
- 将GSC和分化质瘤细胞的代谢概况进行比较.
- 使用药理学抑制剂以准线粒体逆电子运输 (RET).
- 评估了GSC球体形成,SOX2水平,NAD+/NADH比,SIRT3活性和HIF-1α降解.
- 在 орто托普性GBM小鼠和Drosophila脑瘤模型中评估治疗疗效.
主要成果:
- 线粒体RET富含GSCs. 在线粒体RET富含GSCs.
- 抑制RET抑制了GSC球体的形成,并降低了SOX2.
- 抑制RET会增加NAD+/NADH的比率,从而激活SIRT3.
- SIRT3激活导致HIF-1α降解和SOX2抑制.
- 在GBM小鼠模型中,RET抑制延长了生存时间,并在Drosophila中抑制了瘤生长.
结论:
- 线粒体RET对于GSC的维护至关重要.
- 准RET是GBM的一个有前途的治疗策略.
- 这项研究揭示了质母细胞瘤中一种新的代谢脆弱性.
更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
Mitochondrial Membranes
17.5K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.5K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K


